900 patients died without receiving the support they were promised
Hace un año, España prometió por unanimidad apoyo a quienes padecen ELA, una enfermedad que no concede tregua. La promesa llegó sin presupuesto, y en ese vacío entre la intención legislativa y los recursos reales, 900 personas murieron esperando. Esta semana, el Consejo de Ministros aprobó 500 millones de euros para cerrar esa brecha, recordándonos que las leyes sin financiación no son más que palabras, y que el tiempo, para quienes enfrentan enfermedades terminales, es el bien más irreemplazable.
- Una ley aprobada por unanimidad hace un año creó una promesa de apoyo para los pacientes de ELA, pero llegó sin un solo euro asignado para hacerla realidad.
- Durante ese año de vacío presupuestario, 900 pacientes murieron sin haber recibido la ayuda que el Estado les había prometido formalmente.
- Las asociaciones de pacientes acumulan una frustración profunda: describen a sus representados como abandonados y desesperados ante una burocracia que no pudo seguir el ritmo de la enfermedad.
- El decreto aprobado esta semana crea una categoría de 'dependencia extrema' con casi 10.000 euros mensuales por paciente, compartidos entre el gobierno central y las comunidades autónomas.
- El ministro responsable estima que la ayuda podría llegar en semanas, pero la implementación depende de la coordinación territorial, mientras la ELA sigue avanzando sin esperar a nadie.
Hace un año, el parlamento español aprobó por unanimidad una ley para apoyar a los pacientes con ELA, una enfermedad que arrebata el movimiento, la voz y la respiración con una velocidad implacable. La ley llegó sin financiación. Esta semana, el Consejo de Ministros aprobó un decreto que asigna 500 millones de euros para remediar esa ausencia y reforzar el sistema de atención a personas con grandes necesidades de dependencia.
El coste humano del retraso es concreto e irreversible. En España viven en torno a 4.000 personas con ELA en cualquier momento dado. Durante el año transcurrido entre la aprobación de la ley y esta decisión presupuestaria, 900 de ellas murieron sin haber recibido el apoyo prometido. Se quedaron sin tiempo mientras la burocracia intentaba alcanzar a la intención política.
El decreto crea una nueva categoría de 'dependencia extrema' para los casos avanzados de ELA. Los pacientes en esta fase recibirán cerca de 10.000 euros mensuales, financiados a partes iguales entre el gobierno central y las comunidades autónomas. El objetivo es garantizar una atención especializada las 24 horas, una carga que hasta ahora habían asumido solas las familias, cuyo coste anual oscila entre 130.000 y 187.000 euros según las asociaciones de pacientes.
El ministro Pablo Bustinduy indicó que la ayuda podría comenzar a llegar en semanas o pocos meses, sujeta a la coordinación con los consejos territoriales. Desde las asociaciones, la reacción mezcla alivio y dolor acumulado. Pilar Fernández Aporte, de adELA, describió el abandono que han sentido los pacientes; Montxo Iriarte, de ANELA, habló de un abismo entre la política y la ciudadanía que este decreto intenta salvar, aunque reconoció que llega demasiado tarde para quienes no sobrevivieron para verlo. El Estado se mueve ahora. La pregunta es si la velocidad de la implementación podrá, esta vez, seguirle el paso a la enfermedad.
A year ago, Spain's parliament passed a law unanimously to support patients with ALS—a disease that steals movement, speech, and breath with relentless speed. The law arrived with no money attached. On Tuesday, the government finally moved to fix that absence. The Council of Ministers approved a decree allocating 500 million euros to fund care for ALS patients and strengthen the broader system for people with severe dependency needs.
The numbers tell the story of what the delay cost. Roughly 4,000 people in Spain live with ALS at any given moment. During the year between the law's passage and this week's funding decision, 900 of them died without ever receiving the support the law had promised. They ran out of time waiting for bureaucracy to catch up with intention.
The new funding creates what the government calls an "extreme dependency" category—a recognition that advanced ALS requires something beyond the existing framework. Patients in this stage will receive nearly 10,000 euros per month, split evenly between the national government and Spain's regional authorities. The money is meant to guarantee round-the-clock specialized care, a necessity that families had been absorbing alone. According to patient advocacy groups, the annual cost of this care ranges between 130,000 and 187,000 euros—a burden no household can reasonably carry while watching a loved one deteriorate.
Pablo Bustinduy, the minister overseeing social rights, said the assistance could begin flowing within weeks or a few months, pending coordination between the national government and Spain's regional councils. The timeline matters because ALS does not wait. The disease progresses in months, not years. Every week of delay is a week a patient spends without the help they were promised.
The reaction from patient advocates carries the weight of a year's accumulated frustration. Pilar Fernández Aporte, vice president of the adELA patient association, described the emotional toll plainly: patients feel abandoned and desperate because, until now, they had received nothing. Montxo Iriarte, president of ANELA, another major patient group, spoke of a chasm between politicians and citizens—a gap that the decree attempts to bridge, though he acknowledged it arrives too late for those 900 who did not survive to see it.
The decree itself is straightforward in its scope: it funds specialized 24-hour care for people with advanced ALS and other irreversible terminal conditions. It acknowledges that this phase of illness is not something families should navigate alone, and it puts public resources behind that acknowledgment. But the year-long gap between promise and payment has already written its own story into the law's history. The government is moving now. The question is whether the speed of implementation can match the speed of the disease.
Notable Quotes
Patients feel abandoned and desperate because until now they have received nothing— Pilar Fernández Aporte, vice president of adELA patient association
For many patients this funding will not arrive in time—900 patients who could not live the dignified life they deserved during this year have already passed away— Montxo Iriarte, president of ANELA patient association
The Hearth Conversation Another angle on the story
Why did a law pass without funding in the first place?
It's a common pattern in Spanish politics—a bill passes with broad support, everyone celebrates the principle, and then the budget process stalls. The law was unanimous, which meant it had political cover. But that same unanimity sometimes masks disagreement about who pays and how much.
And 900 people died during that year?
Yes. ALS moves fast. Some patients live two to five years from diagnosis. A year is a significant portion of someone's remaining life. Those 900 didn't get to see the money materialize.
Is 10,000 euros a month actually enough?
It covers the specialized care costs—the nurses, the equipment, the medical oversight. But it doesn't cover lost income, the emotional weight, or the fact that families are still doing much of the work. It's a floor, not a solution.
Why split the cost between national and regional governments?
Spain's regions have significant autonomy over healthcare. The national government can't simply impose spending. But that also means implementation depends on 17 different regional councils coordinating. That's where delays happen.
What happens now?
The decree is approved. The territorial council meets to work out the details. In theory, patients start receiving money in weeks. In practice, we'll see if the regional systems can move that fast.